Cite
APA Citation
Rahma, O., Baginska, J., Brainard, M., Giobbie-Hurder, A., Tyan, K., Cleary, J., Schlechter, B., Maloney, A., Manos, M., Romee, R., Severgnini, M., & Stephen Hodi, F. (n.d.). 808 Exploring resistance mechanism to pembrolizumab and ang-2 inhibitor trebananib (NCT03239145) using high-dimensional single-cell mass cytometry (CyTOF). Journal for immunotherapy of cancer, 8, A483–A484. http://access.bl.uk/ark:/81055/vdc_100144723131.0x000004